InnovAge appoints James Carlson as non-executive Chairman effective June 30, 2022

InnovAge Holding Corp.

Carlson will serve as Class II director and Chairman until the 2023 annual meeting.
Received RSU grant worth $125,000 (vests in one year) plus annual retainers totaling $200,000.
Previously CEO of Amerigroup (sold to WellPoint for ~$5B) and EVP at UnitedHealth Group.
Board expands from nine to ten directors; Carlson is independent.
Andrew Cavanna steps down as Chairman; Carlson selected under shareholder nomination agreement.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

James G. Carlson

Chairman of the Board

INNV · InnovAge Holding Corp.

Effective: 2022-06-30
Filed: June 30, 2022, 7:59 PM ET

On June 30, 2022, InnovAge Holding Corp. (the “Company”) announced that James G. Carlson had joined the Company’s Board of Directors as Chairman of the Board and a member of the Compensation, Nominating and Governance Committee.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James G. Carlson was appointed as Chairman of the Board at InnovAge Holding Corp..

Action: appointed
Role: Chairman of the Board

Exact text from the filing

On June 30, 2022, InnovAge Holding Corp. (the “Company”) announced that James G. Carlson had joined the Company’s Board of Directors as Chairman of the Board and a member of the Compensation, Nominating and Governance Committee.

View on SEC.gov

InnovAge Holding Corp. filing history →

Source: SEC EDGAR

accession 0001104659-22-076315

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.